“Bleomycin-induced pulmonary hypertension: an underrated phenomenon with important implications in the setting of high-risk clinical scenarios” (2024) Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 41(2), p. e2024012. doi:10.36141/svdld.v41i2.15479.